Evogene EVGN Stock
Evogene Price Chart
Evogene EVGN Financial and Trading Overview
| Evogene stock price | 0.55 USD |
| Previous Close | 0.54 USD |
| Open | 0.56 USD |
| Bid | 0.38 USD x 200 |
| Ask | 0.71 USD x 200 |
| Day's Range | 0.54 - 0.56 USD |
| 52 Week Range | 0.37 - 1.5 USD |
| Volume | 15.03K USD |
| Avg. Volume | 1.88M USD |
| Market Cap | 8.68M USD |
| Beta (5Y Monthly) | 0.683 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.78 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.15 USD |
EVGN Valuation Measures
| Enterprise Value | 9.13M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.687 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.24107 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.507 |
| Enterprise Value/EBITDA | -0.653 |
Trading Information
Evogene Stock Price History
| Beta (5Y Monthly) | 0.683 |
| 52-Week Change | -56.79% |
| S&P500 52-Week Change | 19.66% |
| 52 Week High | 1.5 USD |
| 52 Week Low | 0.37 USD |
| 50-Day Moving Average | 0.53 USD |
| 200-Day Moving Average | 0.81 USD |
EVGN Share Statistics
| Avg. Volume (3 month) | 1.88M USD |
| Avg. Daily Volume (10-Days) | 272.11K USD |
| Shares Outstanding | 15.8M |
| Float | 12.19M |
| Short Ratio | 0.39 |
| % Held by Insiders | 27.86% |
| % Held by Institutions | 6.36% |
| Shares Short | 232.08K |
| Short % of Float | 1.47% |
| Short % of Shares Outstanding | 1.46% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -738.61% |
| Gross Margin | -67.59% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.79% |
| Return on Equity (ttm) | -182.74% |
Income Statement
| Revenue (ttm) | 1.66M USD |
| Revenue Per Share (ttm) | 0.17 USD |
| Quarterly Revenue Growth (yoy) | -60.69% |
| Gross Profit (ttm) | -1120000 USD |
| EBITDA | -13971000 USD |
| Net Income Avi to Common (ttm) | -17832000 USD |
| Diluted EPS (ttm) | -1.75 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.32M USD |
| Total Cash Per Share (mrq) | 0.69 USD |
| Total Debt (mrq) | 2.1M USD |
| Total Debt/Equity (mrq) | 36.43 USD |
| Current Ratio (mrq) | 3.566 |
| Book Value Per Share (mrq) | -0.243 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10947000 USD |
| Levered Free Cash Flow (ttm) | -2041250 USD |
Profile of Evogene
| Country | United States |
| State | N/A |
| City | Rehovot |
| Address | 13 Gad Feinstein Street |
| ZIP | 7638517 |
| Phone | 972 8 931 1900 |
| Website | https://www.evogene.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 38 |
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Q&A For Evogene Stock
What is a current EVGN stock price?
Evogene EVGN stock price today per share is 0.55 USD.
How to purchase Evogene stock?
You can buy EVGN shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evogene?
The stock symbol or ticker of Evogene is EVGN.
Which industry does the Evogene company belong to?
The Evogene industry is Biotechnology.
How many shares does Evogene have in circulation?
The max supply of Evogene shares is 15.8M.
What is Evogene Price to Earnings Ratio (PE Ratio)?
Evogene PE Ratio is now.
What was Evogene earnings per share over the trailing 12 months (TTM)?
Evogene EPS is -1.78 USD over the trailing 12 months.
Which sector does the Evogene company belong to?
The Evogene sector is Healthcare.
Evogene EVGN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26402.42 USD — |
-0.52
|
7.53B USD — | 26359.27 USD — | 26700.68 USD — | — - | 7.53B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2283.3 USD — |
-2.24
|
— — | 2282.89 USD — | 2326.28 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1339.84 USD — |
-2.05
|
— — | 1338.76 USD — | 1360.4 USD — | — - | — — |
- {{ link.label }} {{link}}
